T790M and C797S as Mechanisms of Acquired Resistance to Dacomitinib in Cell Models

被引：0

作者：

Kobayashi, Y. ^{[1
]}

Fujino, T. ^{[1
]}

Nishino, M. ^{[1
]}

Ohara, S. ^{[1
]}

Sesumi, Y. ^{[1
]}

Chiba, M. ^{[1
]}

Shimoji, M. ^{[1
]}

Tomizawa, K. ^{[1
]}

Takemoto, T. ^{[1
]}

Mitsudomi, T. ^{[1
]}

机构：

[1] Kindai Univ, Fac Med, Thorac Surg, Osaka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

EGFR; Dacomitinib; Acquired resistance;

D O I：

10.1016/j.jtho.2017.09.1588

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02-059

引用

页码：S2258 / S2259

页数：2

共 50 条

[1] EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib
Kobayashi, Yoshihisa
Fujino, Toshio
Nishino, Masaya
Koga, Takamasa
Chiba, Masato
Sesumi, Yuichi
Ohara, Shuta
Shimoji, Masaki
Tomizawa, Kenji
Takemoto, Toshiki
Mitsudomi, Tetsuya
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (05) : 727 - 731
[2] EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib
Kobayashi, Yoshihisa
Azuma, Koichi
Nagai, Hiroki
Kim, Young
Togashi, Yosuke
Sesumi, Yuichi
Nishino, Masaya
Chiba, Masato
Shimoji, Masaki
Sato, Katsuaki
Tomizawa, Kenji
Takemoto, Toshiki
Nishio, Kazuto
Mitsudomi, Tetsuya
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1266 - S1267
[3] Structural pharmacological studies on EGFR T790M/C797S
Kong, Lu-Lu
Ma, Rui
Yao, Ming-Yu
Yan, Xiao-E.
Zhu, Su-Jie
Zhao, Peng
Yun, Cai-Hong
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 488 (02) : 266 - 272
[4] Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer
Kobayashi, Yoshihisa
Azuma, Koichi
Nagai, Hiroki
Kim, Young Hak
Togashi, Yosuke
Sesumi, Yuichi
Chiba, Masato
Shimoji, Masaki
Sato, Katsuaki
Tomizawa, Kenji
Takemoto, Toshiki
Nishio, Kazuto
Mitsudomi, Tetsuya
[J]. MOLECULAR CANCER THERAPEUTICS, 2017, 16 (02) : 357 - 364
[5] T790M or C797S Confers Acquired Resistance to Tarloxotinib and Poziotinib in EGFR Exon 20 Insertion-Driven Lung Cancer Models in Vitro
Suda, K.
Nishino, M.
Koga, T.
Fujino, T.
Ohara, S.
Soh, J.
Vellanki, A.
Tirunagaru, V.
Misudomi, T.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S835 - S835
[6] Brigatinib/cetuximab/osimertinibChemotherapy resistance secondary to C797S mutation in cis with T790M: case report
[J]. Reactions Weekly, 2019, 1753 (1) : 81 - 81
[7] Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Jia, Yong
Yun, Cai-Hong
Park, Eunyoung
Rcan, Dalia E.
Manuia, Mari
Juarez, Jose
Xu, Chunxiao
Rhee, Kevin
Chen, Ting
Zhang, Haikuo
Palakurthi, Sangeetha
Jang, Jaebong
Lelais, Gerald
DiDonato, Michael
Bursulaya, Badry
Michellys, Pierre-Yves
Epple, Robert
Marsilje, Thomas H.
McNeill, Matthew
Lu, Wenshuo
Harris, Jennifer
Bender, Steven
Wong, Kwok-Kin
Janne, Pasi A.
Eck, Michael J.
[J]. NATURE, 2016, 534 (7605) : 129 - +
[8] Brigatinib/cetuximab/osimertinibChemotherapy resistance secondary to C797S mutation in cis with T790M: case report
[J]. Reactions Weekly, 2019, 1778 (1) : 99 - 99
[9] Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia
Cai-Hong Yun
Eunyoung Park
Dalia Ercan
Mari Manuia
Jose Juarez
Chunxiao Xu
Kevin Rhee
Ting Chen
Haikuo Zhang
Sangeetha Palakurthi
Jaebong Jang
Gerald Lelais
Michael DiDonato
Badry Bursulaya
Pierre-Yves Michellys
Robert Epple
Thomas H. Marsilje
Matthew McNeill
Wenshuo Lu
Jennifer Harris
Steven Bender
Kwok-Kin Wong
Pasi A. Jänne
Michael J. Eck
[J]. Nature, 2016, 534 : 129 - 132
[10] Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Kenneth S Thress
Cloud P Paweletz
Enriqueta Felip
Byoung Chul Cho
Daniel Stetson
Brian Dougherty
Zhongwu Lai
Aleksandra Markovets
Ana Vivancos
Yanan Kuang
Dalia Ercan
Sarah E Matthews
Mireille Cantarini
J Carl Barrett
Pasi A Jänne
Geoffrey R Oxnard
[J]. Nature Medicine, 2015, 21 : 560 - 562

← 1 2 3 4 5 →